Back

Healthcare resource utilization (HCRU) and disease burden of hypertrophic cardiomyopathy: a nationwide population-based study from Sweden

30 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Real-world cardiovascular care: health economics, resource use, and long-term outcomes Health Economics ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Oscar Braun

Skane University Hospital, Lund (Sweden)

5 More presentations in this session

Presentation thumbnail
Ten-year drug consumption for rare cardiovascular diseases in 66 countries and regions: a multinational drug utilization analysis
Doctor O. Chou (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Acoramidis reduces days lost to death and/or cardiovascular-related hospitalization, preserving time alive outside the hospital in participants with ATTR-CM: results from ATTRibute-CM
Doctor R. Wright (US)
Abstract Slides Video
Presentation thumbnail
Economic evaluation of a large-focal lattice tip catheter versus conventional radiofrequency catheter, for persistent atrial fibrillation ablation, from a German healthcare payer perspective.
Professor R. Wakili (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
The association between body roundness index (BRI) in middle-aged adults and long-term all-cause mortality risk
Mrs E. Friedman Shamay (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Impact of health insurance on long-term mortality after percutaneous coronary intervention in acute coronary syndrome patients: a nationwide propensity-weighted analysis
Mr S. Chumsantivut (Bangkok, TH)
Abstract Slides Video

Access the full session

Session thumbnail
Real-world cardiovascular care: health economics, resource use, and long-term outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Session
Unusual cardiomyopathies: do you know them all?
31 August 2024
thumbnail
Congress Presentation
Real-world clinical and economic outcomes of nonobstructive hypertrophic cardiomyopathy: a german claims data analysis
18 May 2025
thumbnail
Congress Presentation
Cardiovascular disease prevention: the economic imperative
29 August 2026
thumbnail
Congress Presentation
Characterizing disease burden and health care resource utilization in patients with hypertrophic cardiomyopathy: a nationwide real-world study in Finland
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources